Aug 21, 2025 3-5pm ET
Thursday on The Robert Scott Bell Show:
Hour 1
Special Guest: Jonathan Emord
For the past 37 years, Jonathan W. Emord has litigated against the federal bureaucracy, winning over and over again. Ron Paul calls Jonathan “an expert in constitutional theory and history” and “an expert litigator with a long string of legal victories over the federal bureaucracy.” George Noory calls him “a Knight in Shining Armor” and “a warrior out to save our rights.” Congressmen Dan Burton and John Doolittle describe him as “an intellectual warrior for the rights and freedoms of people in America.” Jonathan has a unique, detailed knowledge of the federal bureaucracy, the deep state. He knows how to defeat it. Jonathan graduated from the University of Illinois (BA, political science and history, 1982) and DePaul University College of Law (JD, 1985). He served as an attorney in the Federal Communications Commission during the Reagan administration. A leading constitutional law and litigation expert, he is the author of five critically acclaimed books. He has won more cases against the Food and Drug Administration in federal court than any other attorney in American history, earning him the nickname “FDA Dragon Slayer.” He is a columnist for Townhall.com, PJ Media.com, Americangreatness.com, and the U.S.A. Today Magazine. He frequently appears on national radio and television programs. He is married to Sheryl Emord, and they have two children, twins Justice and Angelica. They reside in Clifton, Virginia.
Grassley Releases Data Showing HHS Put 11K Migrant Children with Unvetted Sponsors Senate Judiciary Committee Chair Senator Chuck Grassley (R-Iowa) revealed that from January 2021 to January 2025, the Department of Health and Human Services (HHS) placed 11,488 unaccompanied alien minors (UAMs) with sponsors who were neither the children’s parents nor legal guardians—and who did not undergo mandatory FBI criminal background checks. Federal law requires digital fingerprint-based vetting for such sponsors, yet approximately 11 percent of placements during that period disregarded this requirement. Additionally, HHS failed to perform home studies for 79,143 migrant children under 12, including 1,961 cases where a study was recommended; this omission affected roughly 10 percent of children mandated to receive one. Grassley criticized the Biden-Harris administration for placing “speed and optics” above child safety and oversight, while praising reforms initiated under Trump-era officials. He underscored previous findings by DHS’s Office of Inspector General that HHS and DHS had lost track of hundreds of thousands of migrant children, often placing them in unsafe housing—such as dilapidated motels or apartments in high-crime areas—which further heightens concerns about danger and exploitation.
RFK Jr. responds to vaccine guidance that goes against CDC: ‘AAP is angry’ Health and Human Services Secretary Robert F. Kennedy Jr. condemned the American Academy of Pediatrics (AAP) for releasing new recommendations urging COVID-19 vaccination for infants and young children in direct contradiction to CDC guidance, which advises shared clinical decision-making rather than a universal recommendation for healthy children. Kennedy accused the AAP of acting under the influence of pharmaceutical industry funding, claiming the organization is prioritizing financial ties over children’s health and describing its guidance as a “pay-to-play scheme.” The AAP defended its position as evidence-based and aimed at protecting children from severe disease, arguing that young children remain at risk for hospitalization and complications. The dispute reflects widening divisions between federal health agencies and professional medical organizations as pandemic policy evolves, with the AAP asserting a need for proactive protection during an uncertain respiratory virus season and the administration stressing caution, limited data on long-term outcomes, and the importance of parental choice in medical decisions. The clash has also raised questions over insurance coverage, since insurers often follow CDC guidance, and highlighted Kennedy’s broader skepticism toward pharmaceutical influence in public health. Critics of the AAP noted the group’s significant funding from drug companies, while supporters emphasized the value of strong pediatric leadership amid conflicting federal signals.
CT pediatricians fight anti-vaccine push targeting education funds Connecticut pediatricians, joined by U.S. Senator Richard Blumenthal, denounced an anti-vaccine campaign pressuring the federal government to cut education funds to states that maintain school vaccine requirements without broad exemptions, warning that such efforts undermine children’s health and put communities at risk. The push, tied to national anti-vaccine groups, argued that states without expanded exemptions should lose federal education support, but physicians countered that Connecticut already maintains one of the highest childhood vaccination rates in the country at nearly 93 percent. Pediatric infectious disease expert Dr. Ian Michelow stressed that vaccines prevent severe illness, intensive care admissions, and long-term complications in children, cautioning that weakening immunization policies could reverse decades of progress in reducing childhood morbidity and mortality. Blumenthal emphasized that linking education funding to vaccination policy is both punitive and reckless, threatening resources schools need to function while jeopardizing public health. Local doctors expressed concern that politicized attacks on vaccination mandates could create confusion among parents, lower uptake, and expose vulnerable populations to preventable outbreaks. The briefing underscored the determination of Connecticut’s medical community to defend vaccination as a cornerstone of pediatric care, while challenging efforts to tie education budgets to ideological battles over vaccine policy.
MAHA leaders may take aim at pharma DTC advertising Leaders within the Make America Healthy Again (MAHA) commission signaled that direct-to-consumer pharmaceutical advertising could face increased scrutiny under the final report expected later this year, with attention focused on the rise of drug marketing through social media and telehealth platforms. The draft report notes that consumers are being targeted by “deceptive” and incomplete promotions that fail to disclose the full scope of risks, creating an environment in which patients are nudged toward expensive or unnecessary prescriptions without informed consent. While the draft does not call for an outright ban on DTC advertising, it raises the prospect of stricter enforcement measures, including mandatory comprehensive disclosure of side effects, heightened labeling standards for digital ads, and civil penalties for companies or influencers who misrepresent drug safety. Such proposals reflect a growing recognition that the U.S., one of only two countries permitting DTC pharmaceutical ads, has created a culture of over-prescription driven as much by marketing as by medical necessity. The debate is politically charged: health advocates argue that unchecked advertising contributes to overmedication, while pharmaceutical companies warn that new restrictions could limit patient awareness of treatment options. Ultimately, MAHA leaders present the initiative as a balance between consumer protection and industry transparency, but the report’s language indicates that Kennedy and Trump’s administration is open to reshaping how drug promotion operates in the U.S.
Draft MAHA Report Favors Research, Not Rules The draft version of the Make America Healthy Again (MAHA) commission’s report outlines a strategy that emphasizes research funding, education, and voluntary collaboration over sweeping regulatory changes, reflecting a cautious approach to addressing the chronic disease crisis among American children. Instead of proposing immediate restrictions on pesticides, processed foods, or chemical exposures, the draft recommends expanded federal research through agencies like the NIH, along with public education campaigns aimed at informing families about nutrition, exercise, and chemical risks. The commission’s earlier assessment identified unhealthy diets, sedentary lifestyles, excessive reliance on pharmaceuticals, and environmental toxins as central drivers of disease, raising expectations that bold reforms would follow, but the draft falls short of implementing binding regulations, disappointing advocates who wanted bans or limits on harmful substances and stronger oversight of the food and pharmaceutical industries. Supporters argue that prioritizing research will build a stronger evidence base and foster voluntary industry shifts without creating regulatory backlash, while critics warn that the absence of enforceable policies leaves vulnerable populations at risk and allows corporations to continue practices linked to obesity, diabetes, and developmental disorders. The draft report reflects a tension between public health advocates calling for decisive rules and policymakers seeking incremental strategies that emphasize study and persuasion over compulsion.
Pesticides test MAHA-MAGA alliance The “Make America Healthy Again” (MAHA) movement—led by HHS Secretary Robert F. Kennedy Jr.—is experiencing growing tensions with its Republican allies amid disputes over pesticide regulation. A coalition of MAHA-aligned health advocates, including Mothers Across America and Children’s Health Defense, have formally urged President Trump to reject provisions in a House appropriations bill that would broadly shield pesticide and “forever chemical” manufacturers from liability and impede critical safety assessments of over 57,000 synthetic chemicals, warning such protections could alienate voters and cost the GOP control of the House midterms. The delay in releasing MAHA’s follow-up children’s health report—expected to address environmental toxins like pesticides—suggests these disagreements may be at the heart of political hesitance. Though MAHA’s initial report acknowledged the health dangers associated with pesticide exposure, algorithmic contradictions have emerged between Kennedy’s public health agenda and the deregulatory posture of the EPA under Administrator Lee Zeldin, which has watered down restrictions on glyphosate, atrazine, PFAS, lead, and mercury. Some MAHA supporters see Kennedy’s ability to push for meaningful reform as severely limited by these internal policy conflicts; while he has made gains by eliminating certain food dyes and revising fluoride policy, his influence is compromised by an administration that continues to dismantle environmental safeguards. A spokesperson for HHS maintains that Kennedy remains in dialogue with federal partners and committed to aligning policies with science, yet the growing impatience among constituents reflects frustration with the rising contradictions between public health objectives and regulatory realities.
Hour 2
A Healthcare System That Prevents Chronic Disease America’s healthcare system, once admired globally, now underperforms compared to peer nations—despite significantly higher spending—because it continues to be built around acute, reactive “sick-care” rather than proactive chronic disease prevention; chronic conditions now affect more than 204 million Americans, revealing that the system was never designed to meet the needs of today’s health challenges. Policymakers, clinicians, and philanthropists are urged to spark a “creative explosion” by integrating cutting-edge technologies—such as treatment tracking systems, personalized genetic therapies, and preventive care programs—that extend beyond traditional hospital walls and lighten burdens on overworked providers by keeping patients healthy and out of clinical care. There is a stark disconnect between top-tier U.S. research and its translation into patient-centered care: the innovation exists, but not the delivery mechanisms. The authors posit that transforming hospitals from being crisis responders to preventative health hubs is essential. By leveraging modern digital tools and individualized prevention strategies, the healthcare system can shift from reactive to anticipatory care, empowering providers to focus resources on urgent cases while reducing the prevalence and impact of chronic disease at scale.
Walk for Autism Health Autism Health Inc., a 501(c)(3) public charity (EIN 99-3862116), is hosting the 3K Autism Health Walk—“Every Step for Autism, Every Mile A Miracle!”—at Huntington Beach Central Park West (18381 Goldenwest St, Huntington Beach, CA) on Saturday, September 6, 2025, with on-site registration opening at 8:00 a.m. PDT, a dance warm-up at 9:30, the national anthem at 9:55, the walk beginning at 10:00, awards and sponsor remarks at 1:00 p.m., group dancing at 1:30, and the resource fair closing at 4:00; the event will not be livestreamed, refunds are not offered, and virtual walkers may complete the walk on their own schedule. As displayed on the campaign page, fundraising stands at $4,696 from 86 supporters, equaling 3% of the $150,000 goal, and participants are invited to register or donate through the verified organizer page. The team leaderboard is led by Holloway Roofing (42 members, $3,125), followed by Firefighters 4 Autism ($260), Team Warrior Mom ($171), Team Florida ($165), Castellini Crew ($160), Autism Prayer Team ($150), The freedom team ($80), Joey’s Voice ($70), A Voice For Choice Advocacy ($25), and Superstar Sewells ($25). The page identifies Autism Health Inc. as the organizer with a verified badge and provides a consolidated event schedule and location details to support planning by attendees and teams, emphasizing a community-focused fundraising walk with an in-person resource fair and optional virtual participation to broaden access and contributions.
Think You Can Trust CDC Data? Think Again. The article details allegations raised by Dr. Robert Malone and investigative journalists Maryanne Demasi and Yaffa Shir-Raz that the CDC misled its Advisory Committee on Immunization Practices (ACIP) regarding data on Merck’s monoclonal antibody Clesrovimab, recently approved for use against RSV in newborns whose mothers had not received an RSV vaccine. ACIP voted 5–2 to approve the treatment, with Malone among those supporting it based on information he believed was complete and vetted by the CDC. Later, Demasi and Shir-Raz revealed that critical safety findings, including excess deaths in trial treatment arms, were not disclosed to the committee. In trials of Sanofi–AstraZeneca’s similar antibody nirsevimab, 12 deaths were recorded among 3,710 recipients compared to 4 deaths in 1,797 controls, a consistent imbalance that suggested potential risk. Malone admitted he erred in trusting CDC summaries and vowed never again to assume their transparency. He noted omissions in June 2025 shaped how evidence was framed for policymakers, effectively concealing mortality trends that could have altered ACIP’s decision. Professor Retsef Levi, one of two dissenting votes, underscored that four separate trials showed deaths trending against the treatment. The report questions whether such omissions were gross negligence or intentional manipulation by CDC officials influenced by pharmaceutical interests. It highlights systemic concerns that the CDC’s data practices may be compromised, undermining both federal transparency and public safety. The authors argue that if data falsification occurred, it constitutes a crime and demands accountability, as children’s lives may have been endangered. They conclude that Secretary Robert F. Kennedy Jr.’s calls for reform are validated by these revelations, and that without reliable, gold-standard data, public health decisions will remain corrupted by conflicts of interest.
Illinois becomes 1st state to require student mental health screenings Illinois Governor J.B. Pritzker signed SB 1560 into law, making Illinois the first U.S. state to mandate annual mental health screenings for all public school students in grades 3 through 12 beginning in the 2027–2028 school year. The measure places behavioral health checks alongside vision and hearing exams, shifting the focus from reactive crisis response to proactive prevention and early identification of mental health needs. The Illinois State Board of Education is tasked with creating screening tools, policies, and guidelines by September 1, 2026, and the state will provide schools with free access to the required tools and technology to ensure uniform implementation. Governor Pritzker described the effort as an urgent response to rising rates of anxiety and depression among youth, emphasizing the responsibility of schools to address mental health as part of student well-being. State Superintendent Tony Sanders noted that universal screening can help teachers and administrators recognize issues before they escalate, ensuring that students remain academically prepared and able to succeed long term. The law also links schools with the BEACON Portal, a statewide resource designed to connect families with mental health services and streamline care navigation. While widely praised as a groundbreaking step in school health policy, the law has drawn concerns from some parents and policy advocates over privacy, confidentiality, and the potential for government overreach, with questions about data management and opt-out options still to be resolved.
Question of The Day!
Hi Robert and Super Don, my husband’s heart doctor agreed to take him off of Eliquis but he said he needs the lasix because he still has swelling in his lower legs and he said watch how much salt he eats. What do you recommend?
Thank you! – Yolanda
Welcome to another Homeopathic Hits segment on The Robert Scott Bell Show!
On The Robert Scott Bell Show today, we focus on Lilium Tigrinum—prepared from the Tiger Lily plant
Known for its intense action on the female reproductive organs, heart, and mental state, this remedy addresses a unique combination of uterine pressure, cardiac palpitations, and emotional turmoil, often with constant restlessness.
Download the Information Sheet
Remember Friends, The Power to Heal is Yours!
